Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Solid Tumor Basic Panel by NGS is 14 days.

What are the prerequisites for the test Solid Tumor Basic Panel by NGS

  • Specimen Type: Formalin-fixed, paraffin-embedded (FFPE) solid tumor tissue
  • Specimen Volume: Minimum of 10 slides with at least 20% tumor content
  • Specimen Handling: Tissue must be fixed in formalin for at least 6 hours and not exceed 72 hours before processing
  • Turnaround Time: 7-10 business days
  • Storage: Tissue blocks should be stored at room temperature

What are the measure values for the test Solid Tumor Basic Panel by NGS

  • Gene Panel: Solid Tumor Basic Panel
  • Method: Next Generation Sequencing (NGS)
  • Measure Values:
    • EGFR - Exon 18, 19, 20, 21: Mutation Status (Wild Type/Mutant)
    • KRAS - Exon 2, 3, 4: Mutation Status (Wild Type/Mutant)
    • BRAF - Exon 15: Mutation Status (Wild Type/Mutant)
    • NRAS - Exon 2, 3, 4: Mutation Status (Wild Type/Mutant)
    • PIK3CA - Exon 10, 21: Mutation Status (Wild Type/Mutant)

What does this test Solid Tumor Basic Panel by NGS identify?

Test: Solid Tumor Basic Panel by NGS

The Solid Tumor Basic Panel by NGS is a comprehensive genetic test that uses Next-Generation Sequencing (NGS) technology to identify mutations in genes associated with solid tumors. This panel is designed to detect genetic alterations in a wide range of solid tumor types, including but not limited to lung cancer, breast cancer, colorectal cancer, and melanoma.

By analyzing the DNA from a tumor sample, this test can provide valuable information about the specific genetic changes driving the growth and progression of the cancer. This information can help oncologists make more informed treatment decisions, including targeted therapies and clinical trial options.

Overall, the Solid Tumor Basic Panel by NGS is a powerful tool for identifying actionable mutations in solid tumors, guiding personalized treatment strategies, and improving patient outcomes.

Why is this test Solid Tumor Basic Panel by NGS taken?

Why is the Solid Tumor Basic Panel by NGS taken?

The Solid Tumor Basic Panel by NGS is taken to help diagnose and guide treatment for various types of solid tumors. This test utilizes Next-Generation Sequencing (NGS) technology to analyze the genetic makeup of the tumor, which can provide valuable information for personalized treatment decisions.

Specifically, the test can identify genetic mutations and alterations in the tumor that may be driving its growth. This information can help oncologists determine the most effective targeted therapies or immunotherapies for the patient. Additionally, the test can also provide information on potential resistance mechanisms or prognostic markers, which can further inform treatment decisions.

Overall, the Solid Tumor Basic Panel by NGS is a valuable tool in the management of solid tumors, as it can help tailor treatment plans to the individual characteristics of the tumor, leading to more personalized and effective care for patients.

No FAQs available.

Customer Google Rating